drugset / Trial / NCT04300621

A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Participants

NCT04300621

Phase 1 Completed 16 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOpen-labelOther

Summary

The purpose of the study in healthy participants is to characterize the plasma pharmacokinetic (PK) profile of different single dose Oral Thin Film (OTF) (S)-ketamine formulations administered sublingually.

Timeline

Start
2020-06-19
Primary completion
2020-08-10
Completion
2020-08-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified Other

Indications

No indication recorded.